The Global Migraine Drugs Market size was valued at USD 1.80 billion in 2019 and is predicted to reach USD 2.44 billion by 2030, with a CAGR of 2.8% from 2020-2030.
Migraine is a medical condition pertaining with primary headache disorder with symptoms such as nausea, vomiting, dry mouth, somnolence, and sensitivity to light or sound. The headaches start from one side of the head and are pulsating in nature. In some cases, patients are affected by prevalence of aura. The recurrent headaches can last up to some hours or days, with intensity varying from moderate to severe. Migraine has no permanent cure, but migraine drugs can be used to reduce and prevent migraines.
Access Full Description of this report at:-
https://www.nextmsc.com/report/migraine-drugs-market
Top Companies: Allergan Plc, Abbott Laboratories, AstraZeneca, Endo International Plc., Eisai Co. Ltd., Impax Laboratories, GlaxoSmithKline Plc., Johnson & Johnson, Pfizer Inc., Merck & Co., Teva Pharmaceutical Industries Limited, Sanofi SA and others.
According to the data provided by Migraine Trust in 2017, 1 in 7 people worldwide suffer from migraine, i.e. 2% of the total world population suffer from migraine; thereby, migraine being the third most common disease at global level. This scenario generates a demand for effective migraine drugs with minimal or no side-effects; hence supplementing the growth of migraine drugs market. However, side effects associated with the intake of migraine drugs are expected to restrict the growth of migraine drugs market.
Request sample copy of this report at:-
https://www.nextmsc.com/Migraine-Drugs-Market/request-sample
The global migraine drugs market share has been analyzed based on type, route of administration, distribution channel and geography. Based on type, the migraine drugs market is segmented into preventive medicine and abortive medicine. The abortive medicine segment is sub segmented into Triptans (Serotonin Receptor Agonists), Ergotamine Derivative, and others. The preventive medicine is further divided into Anticonvulsant, Antidepressant, Beta Blocker, and others. Based on distribution channel, the migraine drugs market is divided into hospital-based pharmacies, retail pharmacies, and online pharmacies. Geographic breakdown and analysis of each of the previously mentioned segments include regions comprising North America, Europe, Asia-Pacific, and RoW.
About Next Move Strategy Consulting:
Next Move Strategy Consulting is an independent and trusted third-platform market intelligence provider, committed to deliver high quality, market research reports that help multinational companies to triumph over their competitions and increase industry footprint by capturing greater market share. Our research model is a unique collaboration of primary research, secondary research, data mining and data analytics.
We have been servicing over 1000 customers globally that includes 90% of the Fortune 500 companies over a decade. Our analysts are constantly tracking various high growth markets and identifying hidden opportunities in each sector or the industry. We provide one of the industry’s best quality syndicate as well as custom research reports across 10 different industry verticals. We are committed to deliver high quality research solutions in accordance to your business needs. Our industry standard delivery solution that ranges from the pre consultation to after-sales services, provide an excellent client experience and ensure right strategic decision making for businesses.
For more insights, please visit, https://www.nextmsc.com
